Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,131.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
101.17
(
2.92%
)
Bitcoin
74,482.52
(
-0.48%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jellybean

Send PM Follow Ignore
Followers 10
Posts 1099
Boards Moderated 0
Alias Born 08/23/2004

jellybean

Re: DewDiligence post# 131657

Tuesday, 11/22/2011 5:15:00 PM

Tuesday, November 22, 2011 5:15:00 PM

Post# of 257253
The patent did have a final rejection that was appealed by AMGN. It looks to me as if he issuance was based on AMGN having further characterized Enbrel to more precisely defined how and why the molelcule works. FYI, I didn't read the entire prosecution just portions of the appeal summary.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today